Hints and tips:
Related Special Reports
...About 40 per cent of the votes cast at the group’s annual meeting in 2021 were against the remuneration plan, which is set every three years....
...Under the approved plans, Soriot could earn a maximum of £18.7mn....
...Lars Fruergaard Jørgensen, chief executive of Novo Nordisk, Europe’s largest pharma group by market capitalisation, was paid DKr68mn (£7.8mn) last year....
...J&J’s medtech division has outstripped the growth of the company’s drugs and diagnostics business, generating $30.4bn in sales last year, or 35 per cent of group revenues....
...The group had a market value of $600mn, as of market close on Friday....
...The positive data will also be a boon to Eli Lilly’s efforts to push for more widescale coverage of the drugs by private insurers and US federal health insurance programme Medicare, which were both initially...
...Others in the sector were down more than 3 per cent, including Solventum, the healthcare group that was spun out from 3M earlier this week....
...Aardvark plans to use the proceeds from its pre-IPO round to fund a late-stage clinical study into ARD-101’s efficacy on Prader-Willi patients and into patients withdrawing from GLP-1 drugs after weight...
...It has abandoned plans for two treatments already. It is working on developing a once-a-day version of its own obesity pill danuglipron after dropping plans for a twice-daily pill....
...The company plans to keep its three dealership sites in Poland, which it will absorb into the distribution arm of its business....
...I’ve got another meeting with Wes Streeting and Peter Kyle about AI in the health service tomorrow. Feel like I am making headway....
...“We’re positioning the company for the long-term health of the business and the market doesn’t necessarily operate that way,” she said....
...“The next few days will be crucial because at the moment there’s no plan,” they said....
...Matthew Taylor, chief executive of the NHS Confederation, which represents health groups across the country, said the £3.4bn additional investment in technology over the next parliament had the potential...
...A senior EU court adviser has said the European Commission was wrong to block gene sequencing group Illumina’s $8bn acquisition of Grail and that the decision should be scrapped....
...The shares fell about 8 per cent to €26 on Tuesday, giving the group a market value of €25.6bn....
...US data analytics group Palantir has secured an NHS England contract worth £330mn to develop a new patient data platform, the health service announced on Tuesday....
...Menopause has risen up employers’ agenda as acceptance grows that once-private issues, such as mental health, have an impact on working life....
...A decade later, that difference had reached more than two-thirds, the group said. “Europe is losing R&D....
...The UK government has told the country’s port authorities that it will not “turn on” critical health and safety checks for EU imports when post-Brexit border controls begin this month because of the risk...
...Pfizer is abandoning its plans for a weight loss pill to be taken twice a day after trials showed it caused significant side effects, in a setback to the US drugmaker’s effort to enter the fast-growing market...
...In March, officials from 194 countries came together to agree on a global plan to deal with a threat known as “Disease X”....
...Joe Biden, his Democratic successor, reversed the plan....
...in the age group....
...Almost 36 per cent of shareholders voted against the plans, under which Soriot could earn annual incentive payments based on long-term performance worth up to 850 per cent of his almost £1.5mn base salary...
International Edition